SCHEMBL7302964

SCHEMBL7302964

COc1ccc(F)cc1Oc1c(Cl)ncnc1NS(=O)(=O)c1ccc(C(C)C)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 5/20 0.47
EDNRB P24530 3/20 0.47
ESR1 P03372 1/20 0.43
ALDH1A1 P00352 4/20 0.42
LMNA P02545 3/20 0.42
MAPT P10636 2/20 0.42
SLC22A12 Q96S37 4/20 0.41
TSHR P16473 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
CNR1 P21554 1/20 0.40
HTT P42858 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40
POLB P06746 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.39
PKM P14618 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7303081 0.91 LMNA (0.48) EDNRAEDNRBESR1ALDH1A1LMNA
SCHEMBL7303662 0.89 EDNRA (0.55) EDNRAEDNRBESR1
SCHEMBL7297111 0.88 EDNRA (0.57) EDNRAEDNRB
SCHEMBL7303175 0.88 MEN1 (0.51) EDNRAEDNRBESR1ALDH1A1LMNA
SCHEMBL7296548 0.85 EDNRA (0.64) EDNRAEDNRB
SCHEMBL7306773 0.84 EDNRA (0.57) EDNRAEDNRB
SCHEMBL7302591 0.82 EDNRA (0.45) EDNRAEDNRBESR1MEN1KMT2A
SCHEMBL7293909 0.79 ESR1 (0.44) EDNRAEDNRBESR1ALDH1A1LMNA
SCHEMBL6783690 0.78 EDNRA (0.67) EDNRAEDNRB
SCHEMBL627598 0.76 EDNRA (0.70) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0526708-B1 Sulfonamide, preparation and use thereof as medicine and intermediate HOFFMANN LA ROCHE (CH) 2000-10-18 EP disclosed
US-5292740-A Sulfonamides HOFFMANN-LA ROCHE INC. (US) 1994-03-08 US disclosed
EP-0526708-A1 Sulfonamide, preparation and use thereof as medicine and intermediate F. HOFFMANN-LA ROCHE AG (CH) 1993-02-10 EP disclosed